19.08.2025 • Sponsored • Whitepaper

Oligonucleotide Impurity Analysis Using Hydrophilic Interaction Chromatography (HILIC)

Download this complimentary how-to guide today!

Whitepaper cover
© Wiley

This how-to guide aims to provide scientists with comprehensive information on oligonucleotide impurity analysis using HILIC, empowering you to advance your research in this field.

What you will learn about:

  • Optimization strategies for mobile phase and gradient conditions to enhance oligonucleotide impurity analysis using HILIC
  • The integration of HILIC with mass spectrometry (MS) for precise identification and characterization of impurities
  • Techniques to address sensitivity challenges, including reducing adducts and adjusting flow rates
  • Troubleshooting common issues such as poor resolution and irreproducible retention in oligonucleotide impurity analysis

More Information

Oligonucleotides, synthetic DNA/RNA strands used in research and therapeutics, are subject to synthesis errors and degradation that can lead to impurities like shortmers and side reactions. Traditional analytical techniques, such as ion-pairing reversed-phase chromatography (IP-RP) and anion exchange chromatography (AEX), have limitations in terms of sensitivity, selectivity, and mass spectrometry compatibility. In contrast, hydrophilic interaction chromatography (HILIC) has emerged as a powerful method, offering high-resolution separation and compatibility with mass spectrometry for effective impurity profiling.

Access

Click here to register for access to this How-To Guide!

Register Now!

Company

YMC Europe GmbH



Germany

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read